2 weeks Ago By ABMN Staff
Envestnet Asset Management Inc. lowered its position in Encompass Health Co. ( NYSE:EHC – Free Report ) by 10.
7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 277,976 shares of the company’s stock after selling 33,312 shares during the period. Envestnet Asset Management Inc.
owned approximately 0.28% of Encompass Health worth $25,671,000 as of its most recent SEC filing. A number of other institutional investors and hedge funds have also recently modified their holdings of the company.
Vanguard Group Inc. grew its holdings in Encompass Health by 1.3% in the fourth quarter.
Vanguard Group Inc. now owns 10,404,081 shares of the company’s stock worth $960,817,000 after purchasing an additional 138,196 shares during the last quarter. Alliancebernstein L.
P. grew its stake in Encompass Health by 6.0% during the 4th quarter.
Alliancebernstein L.P. now owns 2,076,869 shares of the company’s stock worth $191,799,000 after buying an additional 117,617 shares during the last quarter.
Geode Capital Management LLC increased its position in Encompass Health by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 1,679,774 shares of the company’s stock valued at $155,176,000 after buying an additional 6,164 shares in the last quarter.
Copeland Capital Management LLC raised its stake in Encompass Health by 0.7% in the fourth quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company’s stock valued at $119,418,000 after buying an additional 8,548 shares during the last quarter.
Finally, Norges Bank acquired a new stake in Encompass Health in the fourth quarter worth about $100,637,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.
Insiders Place Their Bets In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.
29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at $6,798,129.
56. This trade represents a 6.79 % decrease in their ownership of the stock.
The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink . 2.10% of the stock is currently owned by company insiders.
Encompass Health Trading Up 0.1 % Encompass Health ( NYSE:EHC – Get Free Report ) last posted its earnings results on Thursday, February 6th. The company reported $1.
17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12.
Encompass Health had a net margin of 8.48% and a return on equity of 17.56%.
As a group, analysts forecast that Encompass Health Co. will post 4.8 EPS for the current year.
Encompass Health Announces Dividend The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a $0.17 dividend.
The ex-dividend date is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.
67%. Encompass Health’s payout ratio is 15.25%.
Wall Street Analyst Weigh In Several equities analysts recently commented on the stock. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $110.
00 price target on shares of Encompass Health in a report on Tuesday, February 11th. Barclays boosted their price objective on shares of Encompass Health from $116.00 to $118.
00 and gave the company an “overweight” rating in a report on Friday, February 7th. StockNews.com lowered Encompass Health from a “buy” rating to a “hold” rating in a research note on Thursday, April 3rd.
Finally, KeyCorp boosted their price target on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Monday, February 10th.
One research analyst has rated the stock with a hold rating, nine have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $107.67.
Get Our Latest Analysis on Encompass Health Encompass Health Profile ( Free Report ) Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Featured Stories Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter ..
